Lashinger, Laura M <br/><br/>
Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer.  [electronic resource] 

 -  Cancer prevention research (Philadelphia, Pa.)  Jul 2011 
 - 1041-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1940-6215 
<br/><br/><label>Standard No.: </label>10.1158/1940-6207.CAPR-11-0023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibiotics, Antineoplastic--therapeutic use<br/>Blotting, Western<br/>Body Weight--drug effects<br/>Caloric Restriction<br/>Carcinoma, Pancreatic Ductal--metabolism<br/>Combined Modality Therapy<br/>Disease Models, Animal<br/>Glucose--metabolism<br/>Glucose Tolerance Test<br/>Glycogen Synthase Kinase 3--metabolism<br/>Glycogen Synthase Kinase 3 beta<br/>Immunoenzyme Techniques<br/>Insulin-Like Growth Factor I--metabolism<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Pancreatic Neoplasms--metabolism<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Ribosomal Protein S6 Kinases, 70-kDa--metabolism<br/>STAT3 Transcription Factor--metabolism<br/>Sirolimus--therapeutic use<br/>TOR Serine-Threonine Kinases--metabolism<br/>Tumor Cells, Cultured